• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告显示,免疫功能低下患者的 SARS-CoV-2 持续感染概述了体内病毒进化。

Case reports of persistent SARS-CoV-2 infection outline within-host viral evolution in immunocompromised patients.

机构信息

Microbiology Unit, DIMEC, Alma Mater Studiorum Università di Bologna, Bologna, Italy.

Microbiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

出版信息

Virol J. 2024 Sep 3;21(1):210. doi: 10.1186/s12985-024-02483-y.

DOI:10.1186/s12985-024-02483-y
PMID:39227954
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11373299/
Abstract

BACKGROUND

SARS-CoV-2 is responsible for the ongoing global pandemic, and the continuous emergence of novel variants threatens fragile populations, such as immunocompromised patients. This subgroup of patients seems to be seriously affected by intrahost viral changes, as the pathogens, which are keen to cause replication inefficiency, affect the impaired immune system, preventing efficient clearance of the virus. Therefore, these patients may represent an optimal reservoir for the development of new circulating SARS-CoV-2 variants. The following study aimed to investigate genomic changes in SARS-CoV-2-positive immunocompromised patients over time.

METHODS

SARS-CoV-2-positive nasopharyngeal swabs were collected at different time points for each patient (patient A and patient B), extracted and then analyzed through next-generation sequencing (NGS). The resulting sequences were examined to determine mutation frequencies, describing viral evolution over time.

CASE PRESENTATION

Patient A was a 53-year-old patient with onco-hematological disease with prolonged infection lasting for 51 days from May 28th to July 18th, 2022. Three confirmed SARS-CoV-2-positive samples were collected on May 28th, June 15th and July 4th. Patient B was 75 years old and had onco-hematological disease with prolonged infection lasting for 146 days. Two confirmed positive SARS-CoV-2 samples were collected at the following time points: May 21st and August 18th.

CONCLUSION

Heat map construction provided evidence of gain and/or loss of mutations over time for both patients, suggesting within-host genomic evolution of the virus. In addition, mutation polymorphisms and changes in the SARS-CoV-2 lineage were observed in Patient B. Sequence analysis revealed high mutational pattern variability, reflecting the high complexity of viral replication dynamics in fragile patients.

摘要

背景

SARS-CoV-2 是导致当前全球大流行的罪魁祸首,新型变异株的不断出现威胁着脆弱人群,如免疫功能低下的患者。这类患者亚群似乎受到宿主内病毒变化的严重影响,因为病原体热衷于造成复制效率低下,影响受损的免疫系统,从而阻止病毒的有效清除。因此,这些患者可能是新的循环 SARS-CoV-2 变异株发展的最佳储库。本研究旨在调查随时间推移 SARS-CoV-2 阳性免疫功能低下患者的基因组变化。

方法

对每位患者(患者 A 和患者 B)在不同时间点采集 SARS-CoV-2 阳性鼻咽拭子,提取后通过下一代测序(NGS)进行分析。检查所得序列以确定突变频率,描述病毒随时间的进化。

病例介绍

患者 A 为患有血液肿瘤的 53 岁患者,2022 年 5 月 28 日至 7 月 18 日持续感染 51 天。于 5 月 28 日、6 月 15 日和 7 月 4 日采集了 3 份确诊的 SARS-CoV-2 阳性样本。患者 B 为 75 岁血液肿瘤患者,持续感染 146 天。在以下时间点采集了 2 份确诊的 SARS-CoV-2 阳性样本:5 月 21 日和 8 月 18 日。

结论

热图构建为两位患者提供了病毒随时间获得和/或丢失突变的证据,表明病毒在宿主内的基因组进化。此外,还观察到患者 B 中 SARS-CoV-2 谱系的突变多态性和变化。序列分析显示高突变模式变异性,反映了脆弱患者中病毒复制动力学的高度复杂性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c2/11373299/7c681866a66f/12985_2024_2483_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c2/11373299/b3a43f65d9b6/12985_2024_2483_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c2/11373299/a7452e57db9e/12985_2024_2483_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c2/11373299/ec8af0735aa9/12985_2024_2483_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c2/11373299/ab5a5e829c73/12985_2024_2483_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c2/11373299/7c681866a66f/12985_2024_2483_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c2/11373299/b3a43f65d9b6/12985_2024_2483_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c2/11373299/a7452e57db9e/12985_2024_2483_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c2/11373299/ec8af0735aa9/12985_2024_2483_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c2/11373299/ab5a5e829c73/12985_2024_2483_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50c2/11373299/7c681866a66f/12985_2024_2483_Fig5_HTML.jpg

相似文献

1
Case reports of persistent SARS-CoV-2 infection outline within-host viral evolution in immunocompromised patients.病例报告显示,免疫功能低下患者的 SARS-CoV-2 持续感染概述了体内病毒进化。
Virol J. 2024 Sep 3;21(1):210. doi: 10.1186/s12985-024-02483-y.
2
Virological Aspects of COVID-19 in Patients with Hematological Malignancies: Duration of Viral Shedding and Genetic Analysis.血液系统恶性肿瘤患者中 COVID-19 的病毒学特征:病毒脱落持续时间及基因分析
Viruses. 2024 Dec 31;17(1):46. doi: 10.3390/v17010046.
3
Long-Term Evolution of SARS-CoV-2 in an Immunocompromised Patient with Non-Hodgkin Lymphoma.SARS-CoV-2 在患有非霍奇金淋巴瘤的免疫功能低下患者中的长期进化。
mSphere. 2021 Aug 25;6(4):e0024421. doi: 10.1128/mSphere.00244-21. Epub 2021 Jul 28.
4
Effect of molnupiravir on SARS-CoV-2 evolution in immunocompromised patients: a retrospective observational study.莫努匹韦对免疫功能低下患者中 SARS-CoV-2 进化的影响:一项回顾性观察研究。
Lancet Microbe. 2024 May;5(5):e452-e458. doi: 10.1016/S2666-5247(23)00393-2. Epub 2024 Mar 22.
5
SARS-CoV-2 genomic evolution during a severe and long-lasting omicron infection under antiviral therapy.在抗病毒治疗下严重且持久的奥密克戎感染期间的新型冠状病毒2基因组进化
BMC Infect Dis. 2025 Mar 13;25(1):359. doi: 10.1186/s12879-025-10740-w.
6
SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patient.一名免疫功能低下患者长期感染期间的SARS-CoV-2宿主内进化
Int J Infect Dis. 2022 Sep;122:444-448. doi: 10.1016/j.ijid.2022.06.023. Epub 2022 Jun 18.
7
SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants.SARS-CoV-2 准种为流行变异株提供了有利的突变库。
Microbiol Spectr. 2021 Sep 3;9(1):e0026121. doi: 10.1128/Spectrum.00261-21. Epub 2021 Aug 4.
8
Viral Population Heterogeneity and Fluctuating Mutational Pattern during a Persistent SARS-CoV-2 Infection in an Immunocompromised Patient.免疫功能低下患者持续性 SARS-CoV-2 感染期间的病毒群体异质性和突变模式波动。
Viruses. 2023 Jan 19;15(2):291. doi: 10.3390/v15020291.
9
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients.COVID-19 住院患者中 SARS-CoV-2 感染的持续性及病毒的体内和种间进化。
J Med Virol. 2024 Jun;96(6):e29708. doi: 10.1002/jmv.29708.
10
SARS-CoV-2 evolution during prolonged infection in immunocompromised patients.免疫功能低下患者体内 SARS-CoV-2 的长时间感染过程中的进化。
mBio. 2024 Mar 13;15(3):e0011024. doi: 10.1128/mbio.00110-24. Epub 2024 Feb 16.

引用本文的文献

1
Genomic Epidemiology of Healthcare-Associated Respiratory Virus Infections.医疗保健相关呼吸道病毒感染的基因组流行病学
medRxiv. 2025 Apr 25:2025.04.20.25325828. doi: 10.1101/2025.04.20.25325828.

本文引用的文献

1
SARS-CoV-2 evolution during prolonged infection in immunocompromised patients.免疫功能低下患者体内 SARS-CoV-2 的长时间感染过程中的进化。
mBio. 2024 Mar 13;15(3):e0011024. doi: 10.1128/mbio.00110-24. Epub 2024 Feb 16.
2
SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysis.奥密克戎时期免疫功能低下患者的新冠病毒脱落与演变:一项多中心前瞻性分析
Lancet Microbe. 2024 Mar;5(3):e235-e246. doi: 10.1016/S2666-5247(23)00336-1. Epub 2024 Jan 26.
3
Using big sequencing data to identify chronic SARS-Coronavirus-2 infections.
利用大测序数据识别慢性严重急性呼吸系统综合征冠状病毒 2 感染。
Nat Commun. 2024 Jan 20;15(1):648. doi: 10.1038/s41467-024-44803-4.
4
Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations.暴发信息基因组报告:可扩展和动态监测 SARS-CoV-2 变体和突变。
Nat Methods. 2023 Apr;20(4):512-522. doi: 10.1038/s41592-023-01769-3. Epub 2023 Feb 23.
5
Recurrent SARS-CoV-2 mutations in immunodeficient patients.免疫缺陷患者中出现的新冠病毒(SARS-CoV-2)复发性突变
Virus Evol. 2022 Aug 11;8(2):veac050. doi: 10.1093/ve/veac050. eCollection 2022 Jul.
6
SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients.SARS-CoV-2 脱落动力学和免疫抑制患者中的传播。
Virulence. 2022 Dec;13(1):1242-1251. doi: 10.1080/21505594.2022.2101198.
7
Elucidating the role of N440K mutation in SARS-CoV-2 spike - ACE-2 binding affinity and COVID-19 severity by virtual screening, molecular docking and dynamics approach.通过虚拟筛选、分子对接和动力学方法阐明 SARS-CoV-2 刺突蛋白 N440K 突变与 ACE-2 结合亲和力和 COVID-19 严重程度的关系。
J Biomol Struct Dyn. 2023 Feb;41(3):912-929. doi: 10.1080/07391102.2021.2014973. Epub 2021 Dec 14.
8
Intra-host evolution during SARS-CoV-2 prolonged infection.SARS-CoV-2长期感染期间的宿主体内进化。
Virus Evol. 2021 Sep 29;7(2):veab078. doi: 10.1093/ve/veab078.
9
Different Within-Host Viral Evolution Dynamics in Severely Immunosuppressed Cases with Persistent SARS-CoV-2.严重免疫抑制的持续性新冠病毒感染病例中不同的病毒体内进化动态
Biomedicines. 2021 Jul 13;9(7):808. doi: 10.3390/biomedicines9070808.
10
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations.SARS-CoV-2 中和抗体的亲和力成熟赋予了对病毒逃逸突变的效力、广度和恢复能力。
Immunity. 2021 Aug 10;54(8):1853-1868.e7. doi: 10.1016/j.immuni.2021.07.008. Epub 2021 Jul 30.